Absorption |
Blood-Brain Barrier | BBB+ | 0.9444 |
Human Intestinal Absorption | HIA+ | 0.9863 |
Caco-2 Permeability | Caco2+ | 0.6561 |
P-glycoprotein Substrate | Non-substrate | 0.8342 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8886 |
Non-inhibitor | 0.8354 |
Renal Organic Cation Transporter | Non-inhibitor | 0.9128 |
Distribution |
Subcellular localization | Mitochondria | 0.7099 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.5602 |
CYP450 2D6 Substrate | Non-substrate | 0.9050 |
CYP450 3A4 Substrate | Non-substrate | 0.7689 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8593 |
CYP450 2C9 Inhibitor | Inhibitor | 0.5677 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.8781 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.6175 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.6971 |
CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.6443 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9796 |
Non-inhibitor | 0.8974 |
AMES Toxicity | Non AMES toxic | 0.9392 |
Carcinogens | Non-carcinogens | 0.8709 |
Fish Toxicity | Low FHMT | 0.7468 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.5697 |
Honey Bee Toxicity | Low HBT | 0.8686 |
Biodegradation | Not ready biodegradable | 0.9762 |
Acute Oral Toxicity | III | 0.5486 |
Carcinogenicity (Three-class) | Non-required | 0.4753 |